| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/12/2007 | WO2005076892A3 Method for determining reduced susceptibility of hiv to protease inhibitor treatment |
| 04/12/2007 | WO2005050171A3 Methods and compositions relating to single reactive center reagents |
| 04/12/2007 | WO2005014795A3 Osteoarthritis biomarkers and uses thereof |
| 04/12/2007 | WO2004072268A3 Pkhdl1, a homolog of the autosomal recessive kidney disease gene |
| 04/12/2007 | US20070083954 Novel genes from drought stress tolerant tea plant and a method of introducing water-stress tolerance |
| 04/12/2007 | US20070083334 Methods and systems for annotating biomolecular sequences |
| 04/12/2007 | US20070083333 Modeling of systemic inflammatory response to infection |
| 04/12/2007 | US20070082860 Hla-a24-restricted cancer antigen peptides |
| 04/12/2007 | US20070082847 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 04/12/2007 | US20070082412 for the manipulation of colloidal particulates and biomolecules at the interface between an insulating electrode such as silicon oxide and an electrolyte solution; for fabrication of surface-mounted optical components; drug screening |
| 04/12/2007 | US20070082376 Bioassays for determining if an microorganism produces AmpC beta-lactamase; kits |
| 04/12/2007 | US20070082375 Topically administering to a nail of subject having onychomycosis a therapeutically effective amount of an antifungal compound such as (2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylen piperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol |
| 04/12/2007 | US20070082374 Method of treating a condition associated with phosphorylation of task-1 |
| 04/12/2007 | US20070082373 Processes for regulating blood glucose in a mammal and novel polypeptides useful in NAD biosynthesis |
| 04/12/2007 | US20070082372 Membrane system for blood coagulation testing |
| 04/12/2007 | US20070082365 Protein scaffolds for antibody mimics and other binding proteins |
| 04/12/2007 | US20070082361 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 04/12/2007 | US20070082360 Magnetic pigment |
| 04/12/2007 | US20070082359 Identifying a compound that inhibits assembly of a viral capsid by performing assembly reaction using capsid polypeptides labeled with a fluorescent dye that changes fluorescence at high concentration, resulting in juxtaposition of at least one of the N-terminus and C-terminus where the dye is attached |
| 04/12/2007 | US20070082358 Sequencing by synthesis based ordered restriction mapping |
| 04/12/2007 | US20070082357 Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabolized per se by UGT1A1 enzyme or whose metabolic intermediate is metabolized by the enzyme |
| 04/12/2007 | US20070082356 Methods of evaluating transplant rejection |
| 04/12/2007 | US20070082355 Method for polymerase chain reactions with use of a DNA polymerase with proofreading properties |
| 04/12/2007 | US20070082354 Method for Isolating RNA |
| 04/12/2007 | US20070082353 Genetic marker selection program for genetic diagnosis, apparatus and system for executing the same, and genetic diagnosis system |
| 04/12/2007 | US20070082352 Microscopy tip |
| 04/12/2007 | US20070082351 Reagents, methods and kits for classification of fungi and direction of anti-fungal therapy |
| 04/12/2007 | US20070082350 Assay and method for diagnosing and treating alzheimer's disease |
| 04/12/2007 | US20070082349 detecting a target nucleic acid by detecting the presence of a fluorescent covalent crosslinked product from non-fluorescent precursors |
| 04/12/2007 | US20070082348 Binding an allele specific primer which is accompanied by less possibility of the false positive, measuring the efficiency of DNA elongation |
| 04/12/2007 | US20070082347 Gene variants and use thereof |
| 04/12/2007 | US20070082346 Homogeneous detection method |
| 04/12/2007 | US20070082345 Secretory protein or membrane protein |
| 04/12/2007 | US20070082344 Discrimination method of target base in DNA, and allele specific primer used in the method of the same |
| 04/12/2007 | US20070082343 Method for the control of segment-wise enzymatic duplication of nucleic acids via incomplete complementary strands |
| 04/12/2007 | US20070082342 Near-patient module for analyte detection system |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082340 Using presence of mutation in staphylococcal cassette chromosome (SCC) and polymorphic right extremity junction (MREJ) genic behavior as evaluative tool in predicting methicillin resistance in bacteria |
| 04/12/2007 | US20070082339 Methods and compositions for screening for HDAC inhibitory activity |
| 04/12/2007 | US20070082338 CGH array quality assessment |
| 04/12/2007 | US20070082337 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby |
| 04/12/2007 | US20070082336 Methods for protein labeling based on acyl carrier protein |
| 04/12/2007 | US20070082335 Methods and compositions for treatment of viral infections based on tsg101-vps28 interaction |
| 04/12/2007 | US20070082334 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/12/2007 | US20070082333 Thermophilic dna polymerases from thermoactinomyces vulgaris |
| 04/12/2007 | US20070082332 Molecular cardiotoxicology modeling |
| 04/12/2007 | US20070082331 Chemical processing cartridge and method of using same |
| 04/12/2007 | US20070082330 Providing a plurality of icosahedral phage displaying different compounds; andcontacting the plurality of icosahedral phage with the cell, identifying at least one icosahedral phage displaying a compound that is transported into or through the cell |
| 04/12/2007 | US20070082329 Infertility assessment and treatment system |
| 04/12/2007 | US20070082328 Rotatable time varying electromagnetic force bioreactor and method of using the same |
| 04/12/2007 | US20070082327 Cellular phenotype |
| 04/12/2007 | US20070081997 Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9) |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081990 Regulation of expression of high-affinity immunoglobulin e (ige) receptor beta-chain |
| 04/12/2007 | US20070081987 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer) |
| 04/12/2007 | US20070081983 Isolation of smooth muscle cells and tissue-engineered vasculature containing the isolated cells |
| 04/12/2007 | US20070081974 Antibody targeting osteoclast-associated protein |
| 04/12/2007 | US20070081942 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides |
| 04/12/2007 | US20070080073 Enzymatic electrochemical biosensor |
| 04/12/2007 | US20070080060 Potentiostatic circuit arrangement on a biosensor for digitisation of the measured current |
| 04/12/2007 | DE102005046361A1 Detection and differentiation of Salmonella serovars, especially parathyphi B and Java, useful for analysis of e.g. food, clinical and water samples, based on amplification of gene STM3356 |
| 04/12/2007 | DE102005027796B4 Verfahren zum Auffinden eines Wirkstoffs, welcher ein Abtöten von Tumorzellen bei einer Tumorerkrankung eines Säugetiers oder Menschen ermöglicht Method of finding an active ingredient, which allows killing of tumor cells at a tumor disease of a mammal or human |
| 04/12/2007 | DE102004048462B4 Modellsystem zum Testen von pharmazeutischen Zubereitungen auf Wirksamkeit bei entzündlichen Prozessen im Nervensystem Model system to test pharmaceutical preparations for efficacy in inflammatory processes in the nervous system |
| 04/12/2007 | CA2665080A1 Regulatable fusion promoters |
| 04/12/2007 | CA2625183A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | CA2624936A1 The genetic risk assessment in heart failure: impact of genetic variation of aldosterone synthase promoter polymorphism |
| 04/12/2007 | CA2624917A1 Non-fluorescent energy transfer |
| 04/12/2007 | CA2624796A1 Combination therapy using budesonide and antisense oligonucleotide targeted to il-4 receptor alpha |
| 04/12/2007 | CA2624613A1 Method to predict or monitor the response of a patient to an erbb receptor drug |
| 04/12/2007 | CA2623818A1 Aptamers comprising arabinose modified nucleotides |
| 04/12/2007 | CA2623657A1 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 04/12/2007 | CA2623480A1 Gated voltammetry |
| 04/12/2007 | CA2623050A1 Tetrahymena bifunctional dihydrofolate reductase - thymidylate synthase deficiency and its use |
| 04/12/2007 | CA2622852A1 Tumor angiogenesis associated genes and a method for their identification |
| 04/12/2007 | CA2620667A1 Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity |
| 04/12/2007 | CA2620338A1 Methods of using il-21 |
| 04/11/2007 | EP1772732A1 Polymer replicated interdigitated electrode arrays for (bio)sensing applications |
| 04/11/2007 | EP1772523A2 Method for polymerase chain reactions with use of a dna polymerase with proofreading properties |
| 04/11/2007 | EP1772522A1 Control of preservation by biomarkers |
| 04/11/2007 | EP1772521A1 Methods for the prognosis of cancer patients |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1771735A1 Fluorescent phosphonic ester library |
| 04/11/2007 | EP1771728A2 Methods and compositions for risk stratification |
| 04/11/2007 | EP1771715A2 Predicting alzheimer's disease |
| 04/11/2007 | EP1771585A2 Compositions and methods for detection of hepatitis a virus nucleic acid |
| 04/11/2007 | EP1771583A2 Method for distinguishing methicillin resistant s. aureus from methicillin sensitive s. aureus in a mixed culture |
| 04/11/2007 | EP1771582A2 Modulators of odorant receptors |
| 04/11/2007 | EP1771581A2 Functional variant of lymphoid tyrosine phosphatase is associated with autoimmune disorders |
| 04/11/2007 | EP1771580A1 Diagnostic and prognostic methods of non-alcoholic steatohepatitis (nash) |
| 04/11/2007 | EP1771578A2 Diagnostic and therapeutic use of slim3 for neurodegenerative diseases |
| 04/11/2007 | EP1771577A2 Method for determining the abundance of sequences in a sample |
| 04/11/2007 | EP1771576A1 Active substances for increasing pathogenic defence in plants and methods for the detection thereof |
| 04/11/2007 | EP1771575A1 Single nucleotide polymorphisms as prognostic tool to diagnose adverse drug reactions (adr) and drug efficacy |
| 04/11/2007 | EP1771574A2 Pef-ts expression units comprising corynebacterium glutamicum |
| 04/11/2007 | EP1771570A2 Addition of transgenes into adenoviral vectors |
| 04/11/2007 | EP1771556A2 Determination of a phosphorylation site in ppiase domain of pin1 and uses therefor |
| 04/11/2007 | EP1771554A2 Microbially expressed xylanases and their use as feed additives and other uses |
| 04/11/2007 | EP1771553A1 Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion |
| 04/11/2007 | EP1771552A2 Influenza hemagglutinin and neuraminidase variants |